Cannabinoids in the treatment of cancer

被引:91
作者
Alexander, Amy [1 ]
Smith, Paul F. [1 ]
Rosengren, Rhonda J. [1 ]
机构
[1] Univ Otago, Dept Pharmacol & Toxicol, Dunedin, New Zealand
关键词
Cannabinoids; JWH-133; CB1; CB2; MAPK; ACTIVATED PROTEIN-KINASE; NECROSIS-FACTOR-ALPHA; SELECTIVE ANTAGONIST; RECEPTOR; STIMULATION; INVOLVEMENT; GROWTH; CB1; CELLS; PROLIFERATION;
D O I
10.1016/j.canlet.2009.04.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cannabinoids, the active components of the hemp plant Cannabis sativa, along with their endogenous counterparts and synthetic derivatives, have elicited anti-cancer effects in many different in vitro and in vivo models of cancer. While the various cannabinoids have been examined in a variety of cancer models, recent studies have focused on the role of cannabinoid receptor agonists (both CB1 and CB2) in the treatment of estrogen receptor-negative breast cancer. This review will summarize the anti-cancer properties of the cannabinoids, discuss their potential mechanisms of action, as well as explore controversies surrounding the results. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:6 / 12
页数:7
相关论文
共 51 条
  • [1] Cannabinoid receptors and the regulation of immune response
    Berdyshev, EV
    [J]. CHEMISTRY AND PHYSICS OF LIPIDS, 2000, 108 (1-2) : 169 - 190
  • [2] Endocannabinoids in endocrine and related tumours
    Bifulco, Maurizio
    Malfitano, Anna Maria
    Pisanti, Simona
    Laezza, Chiara
    [J]. ENDOCRINE-RELATED CANCER, 2008, 15 (02) : 391 - 408
  • [3] Cannabinoids and cancer: pros and cons of an antitumour strategy
    Bifulco, Maurizio
    Laezza, Chiara
    Pisanti, Simona
    Gazzerro, Patrizia
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2006, 148 (02) : 123 - 135
  • [4] Inhibition of tumor angiogenesis by cannabinoids
    Blázquez, C
    Casanova, ML
    Planas, A
    del Pulgar, TG
    Villanueva, C
    Fernández-Aceñero, MJ
    Aragonés, J
    Huffman, JW
    Jorcano, JL
    Guzmán, M
    [J]. FASEB JOURNAL, 2003, 17 (01) : 529 - +
  • [5] Cannabinoid receptors as novel targets for the treatment of melanoma
    Blazquez, Cristina
    Carracedo, Arkaitz
    Barrado, Lucia
    Jose Real, Pedro
    Fernandez-Luna, Jose Luis
    Velasco, Guillermo
    Malumbres, Marcos
    Guzman, Manuel
    [J]. FASEB JOURNAL, 2006, 20 (14) : 2633 - +
  • [6] ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASES BY STIMULATION OF THE CENTRAL CANNABINOID RECEPTOR CB1
    BOUABOULA, M
    POINOTCHAZEL, C
    BOURRIE, B
    CANAT, X
    CALANDRA, B
    RINALDICARMONA, M
    LEFUR, G
    CASELLAS, P
    [J]. BIOCHEMICAL JOURNAL, 1995, 312 : 637 - 641
  • [7] Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor - Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression
    Bouaboula, M
    PoinotChazel, C
    Marchand, J
    Canat, X
    Bourrie, B
    RinaldiCarmona, M
    Calandra, B
    LeFur, G
    Casellas, P
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 237 (03): : 704 - 711
  • [8] Δ9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation
    Caffarel, Maria M.
    Sarrio, David
    Palacios, Jose
    Guzman, Manuel
    Sanchez, Cristina
    [J]. CANCER RESEARCH, 2006, 66 (13) : 6615 - 6621
  • [9] Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes
    Carracedo, Arkaitz
    Gironella, Meritxell
    Lorente, Mar
    Garcia, Stephane
    Guzman, Manuel
    Velasco, Guillermo
    Iovanna, Juan L.
    [J]. CANCER RESEARCH, 2006, 66 (13) : 6748 - 6755
  • [10] CASANOVA ML, 2003, J CLIN INVEST